10-环戊基癸酸 | 10592-45-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 10-环戊基癸酸
• 英文名称: ω-Cyclopentyldecansaeure
• 英文别名: Homodihydroaleprinsaeure；10-Cyclopentyldecanoic acid
• CAS: 10592-45-7
• 化学式: C₁₅H₂₈O₂
• 分子量: 240.386
• InChiKey: XMKHJDJISUCUGF-UHFFFAOYSA-N

物化性质

• 沸点：
  361.6±10.0 °C(Predicted)
• 密度：
  0.950±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  6.1
• 重原子数：
  17
• 可旋转键数：
  10
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  癸二酸 、 环戊乙酸 在 sodium 作用下， 以 甲醇 为溶剂， 生成 10-环戊基癸酸
  参考文献：
  名称：

  Tanaka,A., Chemical and pharmaceutical bulletin, 1960, vol. 8, p. 1063 - 1066

  摘要：

  DOI：

文献信息

• Particles, particle dispersion, particle-dispersed resin composition, producing method therefor, resin molded article, producing method therefor, catalyst particles, catalyst solution, catalyst composition, catalyst molded article, titanium complex, titanium oxide particles and producing method therefor
  申请人：NITTO DENKO CORPORATION

  公开号：US10265693B2

  公开（公告）日：2019-04-23

  Organic-inorganic composite particles that can be dispersed in a solvent and/or a resin as primary particles having an organic group on the surface of inorganic particles, the organic-inorganic composite particles having negative birefringence.

  有机-无机复合粒子，可作为初级粒子分散在溶剂和/或树脂中，无机粒子表面带有有机基团，有机-无机复合粒子具有负双折射。
• PARTICLES, PARTICLE DISPERSION, PARTICLE-DISPERSED RESIN COMPOSITION, PRODUCING METHOD THEREFOR, RESIN MOLDED ARTICLE, PRODUCING METHOD THEREFOR, CATALYST PARTICLES, CATALYST SOLUTION, CATALYST COMPOSITION, CATALYST MOLDED ARTICLE, TITANIUM COMPLEX, TITANIUM OXIDE PARTICLES AND PRODUCING METHOD THEREFOR
  申请人：Hatakeyama Yoshiharu

  公开号：US20130109770A1

  公开（公告）日：2013-05-02

  Organic-inorganic composite particles that can be dispersed in a solvent and/or a resin as primary particles having an organic group on the surface of inorganic particles, the organic-inorganic composite particles having negative birefringence.
• LIPOBALANCED LONG CHAIN TESTOSTERONE PRODRUGS FOR ORAL DELIVERY
  申请人：Lipocine Inc.

  公开号：US20140288039A1

  公开（公告）日：2014-09-25

  The present disclosure is drawn to oral pharmaceutical compositions and dosage forms containing select lipobalanced testosterone prodrugs and related methods. In one embodiment of the present invention, an oral pharmaceutical composition for administration to subjects in need of testosterone is provided. The composition comprises a lipobalanced testosterone prodrugs and a pharmaceutically acceptable carrier.
• LIPOBALANCED LONG CHAIN TESTOSTERONE ESTERS FOR ORAL DELIVERY
  申请人：Lipocine Inc.

  公开号：US20190240235A1

  公开（公告）日：2019-08-08

  The present disclosure is drawn to oral pharmaceutical compositions and dosage forms containing select lipobalanced testosterone prodrugs and related methods. In one embodiment of the present invention, an oral pharmaceutical composition for administration to subjects in need of testosterone is provided. The composition comprises a lipobalanced testosterone prodrugs and a pharmaceutically acceptable carrier.
• Tanaka,A., Chemical and pharmaceutical bulletin, 1960, vol. 8, p. 1063 - 1066
  作者：Tanaka,A.

  DOI：——

  日期：——